|
| related topics |
| {customer, product, revenue} |
| {stock, price, operating} |
| {cost, regulation, environmental} |
| {cost, operation, labor} |
| {acquisition, growth, future} |
| {product, liability, claim} |
| {tax, income, asset} |
| {property, intellectual, protect} |
| {provision, law, control} |
| {product, market, service} |
| {regulation, change, law} |
|
|
Intellectual property infringement claims by or against us may result in litigation, the cost of which could be substantial and could prevent us from selling our products.
Our growth could strain our personnel and infrastructure resources, and, if we are unable to implement appropriate controls and procedures to manage our growth, we may not be able to successfully implement our business plan.
Our success depends on our continued investment in research and development, the level and effectiveness of which could reduce our profitability.
We manufacture nearly all of our products at our Oregon facilities, and any disruption in the operations of these facilities could harm our business.
We may fail to comply with environmental regulations, which could result in significant costs and harm our business.
Product liability claims may be asserted against us, resulting in costly litigation for which we may not have sufficient liability insurance.
We rely on a small number of customers for a significant portion of our revenue, and the termination of any of these relationships would adversely affect our business.
Our employment costs in the short-term are, to a large extent, fixed, and therefore, any shortfall in sales would harm our operating results.
The additional costs that we incur as a result of being a public company will affect our operating results.
Unanticipated changes in our tax rates or exposure to additional income tax liabilities could affect our profitability.
Our officers and directors and their affiliates will control the outcome of matters requiring shareholder approval.
The anti-takeover provisions of our charter documents and Oregon law may inhibit a takeover or change in our control that shareholders may consider beneficial.
If our stock price is volatile, securities class action litigation may be brought against us, which could result in substantial costs.
Full 10-K form ▸
|
|
| related documents |
| 933405--3/1/2007--AFTERMARKET_TECHNOLOGY_CORP |
| 768408--6/26/2008--CYANOTECH_CORP |
| 946356--3/9/2007--OAKLEY_INC |
| 1183941--12/15/2008--ACTIVIDENTITY_CORP |
| 933405--3/2/2006--AFTERMARKET_TECHNOLOGY_CORP |
| 1260968--3/9/2007--MARLIN_BUSINESS_SERVICES_CORP |
| 1130950--4/14/2006--EXCELLIGENCE_LEARNING_CORP |
| 708850--8/29/2007--DIONEX_CORP_/DE |
| 703604--3/15/2007--LAWSON_PRODUCTS_INC/NEW/DE/ |
| 764244--4/24/2008--INTERVOICE_INC |
| 833140--3/20/2006--ENPATH_MEDICAL_INC |
| 1183941--12/29/2006--ACTIVIDENTITY_CORP |
| 1040792--3/29/2006--A_CONSULTING_TEAM_INC |
| 1041379--3/11/2009--AFC_ENTERPRISES_INC |
| 856982--3/12/2008--MERIT_MEDICAL_SYSTEMS_INC |
| 351298--11/30/2007--HEI_INC |
| 1183941--12/14/2009--ACTIVIDENTITY_CORP |
| 1183941--12/14/2007--ACTIVIDENTITY_CORP |
| 57497--3/14/2007--LAMSON_&_SESSIONS_CO |
| 911160--5/30/2007--RF_MICRO_DEVICES_INC |
| 911148--3/30/2007--CADUS_CORP |
| 1041379--3/12/2008--AFC_ENTERPRISES_INC |
| 856982--3/14/2006--MERIT_MEDICAL_SYSTEMS_INC |
| 715787--3/16/2007--INTERFACE_INC |
| 856982--3/4/2009--MERIT_MEDICAL_SYSTEMS_INC |
| 883943--5/2/2007--CHRISTOPHER_&_BANKS_CORP |
| 1085653--4/2/2007--ECOLLEGE_COM |
| 768408--6/25/2009--CYANOTECH_CORP |
| 768408--8/16/2007--CYANOTECH_CORP |
| 885245--4/19/2007--BUCKLE_INC |
|